Angiogenesis Inhibitors: all 4,430 studies that test it
Page 30 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaWithdrawnNCT02258009Phase 4
- Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young PatientsCompletedNCT02257502Phase 2
- Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AMLTerminatedNCT02255162Phase 1
- Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02250599Phase 2
- Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast CancerTerminatedNCT02250118Phase 1
- Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With BevacizumabCompletedNCT02248571Phase 4
- A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRCCompletedNCT02246049Phase 2
- Stereotactic Radiotherapy for Wet AMD (STAR)CompletedNCT02243878Phase 3
- HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)Status unknownNCT02239952Not applicable
- Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal CarcinomaCompletedNCT02237924Phase 2
- Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal CancerWithdrawnNCT02235324Phase 2
- Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated LymphomasWithdrawnNCT02228512Phase 1/2
- Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic TreatmentStatus unknownNCT02226289Phase 2
- Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple MyelomaCompletedNCT02219178Phase 2
- Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary AdenocarcinomaCompletedNCT02217956Phase 1
- STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDSCompletedNCT02215980Phase 3
- Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by SurgeryActive, not recruitingNCT02210117Early Phase 1
- Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)CompletedNCT02206503Phase 2
- Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma PatientsCompletedNCT02206425Phase 1/2
- Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular DegenerationCompletedNCT02204683Phase 1
- Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.CompletedNCT02203643Phase 2
- Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and VomitingCompletedNCT02203253Phase 3
- Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing SpondylitisCompletedNCT02201043Phase 2
- Phase I Study of Lenalidomide, Rituximab and Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)TerminatedNCT02200848Phase 1
- The Safety and Efficacy of Pemetrexed Rechallenge With BevacizumabTerminatedNCT02200354Phase 2
- dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.Status unknownNCT02195336Not applicable
- Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome TrialCompletedNCT02193698Phase 2
- Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple MyelomaCompletedNCT02189343Phase 1
- CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)CompletedNCT02187302Phase 2
- Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD)CompletedNCT02185820Phase 1/2
- Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain MetastasesStatus unknownNCT02185352Phase 2
- Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLCTerminatedNCT02179567Phase 2
- Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi SyndromeTerminatedNCT02179151Phase 3
- Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple MyelomaCompletedNCT02176213Phase 2
- Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC PatientsStatus unknownNCT02175446Phase 2
- A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.CompletedNCT02174211Not applicable
- Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase IStatus unknownNCT02173873Phase 1
- Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein OcclusionStatus unknownNCT02169648Not applicable
- Treatment Strategies in Colorectal Cancer Patients with Initially Unresectable Liver-only MetastasesCompletedNCT02162563Phase 3
- Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain MetastasesTerminatedNCT02162537Phase 3
- Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by SurgeryActive, not recruitingNCT02160015Phase 1
- Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and BortezomibStatus unknownNCT02158702Phase 2
- Ranibizumab Treatment for Age-Related Macular DegeneretionStatus unknownNCT02158624Not applicable
- Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in MyelomaWithdrawnNCT02155634Phase 3
- Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple MyelomaStatus unknownNCT02145715Phase 1/2
- Treatment Optimization in Patients With Untreated Multiple MyelomaTerminatedNCT02145598Phase 2/3
- Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein OcclusionCompletedNCT02144662Not applicable
- Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)CompletedNCT02142296Phase 4
- Prophylactic Ranibizumab for Exudative Age-related Macular DegenerationCompletedNCT02140151Phase 1/2
- Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung CancerStatus unknownNCT02139579Phase 2
- Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of PrematurityCompletedNCT02134457Phase 2
- Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula EdemaCompletedNCT02131350Phase 4
- Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal CancerCompletedNCT02129257Phase 2
- Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+CompletedNCT02128061Phase 3
- Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF DosingWithdrawnNCT02127684Phase 2
- Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube CancerCompletedNCT02121990Phase 1
- Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular DegenerationCompletedNCT02121353Phase 1/2
- Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMMCompletedNCT02112175Phase 3
- Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)TerminatedNCT02106520Phase 2/3
- Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related TumorsCompletedNCT02104323Phase 2
- Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple MyelomaCompletedNCT02103335Phase 1
- Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular EdemaCompletedNCT02096874Phase 4
- Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVOStatus unknownNCT02091505Not applicable
- PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASESCompletedNCT02086656Phase 2
- Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell LymphomaCompletedNCT02086604Phase 1
- PEG-ASP+Gemox Regimen and Thalidomide for NK/T LymphomaStatus unknownNCT02085655Phase 3
- Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT02077959Phase 1
- CRIZENT: Crizotinib and Sunitinib in Metastatic Breast CancerTerminatedNCT02074878Phase 1
- Angiogenic Factor Expression During Fractionated IrradiationStatus unknownNCT02072720Early Phase 1
- Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal VasculopathyCompletedNCT02072408Phase 4
- Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell CarcinomaTerminatedNCT02071641Phase 2
- Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal MelanomaActive, not recruitingNCT02068586Phase 2
- Analysis of Aqueous and Vitreous HumorStatus unknownNCT02067013Phase 2
- Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain MetastasesWithdrawnNCT02065466Phase 1/2
- An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic InjuryCompletedNCT02063295Phase 2
- Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)Status unknownNCT02060656Phase 2
- Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular DegenerationCompletedNCT02060604Phase 4
- Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.CompletedNCT02058901Phase 1
- Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular EdemaWithdrawnNCT02055911Phase 4
- Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural EffusionStatus unknownNCT02054078Phase 2
- Intrapleural Bevacizumab Injection for Malignant Effusion in Lung CancerCompletedNCT02054052Phase 2
- The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular EdemaCompletedNCT02050828Phase 2
- Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor CellCompletedNCT02048540Phase 1/2
- Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin TherapyTerminatedNCT02047214Phase 2
- Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and CyclophosphamideCompletedNCT02046915Phase 2
- Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal CancerTerminatedNCT02045030Phase 2
- Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal InsufficiencyCompletedNCT02045017Phase 2
- Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular DegenerationWithdrawnNCT02036723Phase 3
- Aflibercept Intravitreal Injection for Myopic Choroidal NeovascularizationStatus unknownNCT02033018Phase 4
- A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)CompletedNCT02031991Phase 1
- Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple MyelomaTerminatedNCT02030483Phase 1
- Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT02029950Phase 1
- Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal MelanomaStatus unknownNCT02023710Phase 2
- Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian CancerCompletedNCT02022917Phase 2
- Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersCompletedNCT02020707Phase 1
- Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung CancerTerminatedNCT02018523Phase 1
- Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective StudyCompletedNCT02015351Not applicable
- Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric CancerStatus unknownNCT02008422Phase 3
- Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLLCompletedNCT02005289Phase 2
- Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLCStatus unknownNCT02005120Phase 2